Other NER genes were studied, including XPA, XPB, XPF, and XPD, both at the mRNA level and gene polymorphisms, but none have been shown to be correlated with cisplatin resistance in ovarian carcinoma [82,86,90]. This evidence concerns the gene NR1H2 and ovarian carcinoma.